These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 27742220)

  • 41. DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria.
    Noll A; Bücheler N; Bohn E; Schirmbeck R; Reimann J; Autenrieth IB
    Eur J Immunol; 1999 Mar; 29(3):986-96. PubMed ID: 10092103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
    Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
    Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and microbiological response of mice to intranasal inoculation with Lactococcus lactis expressing Group A Streptococcus antigens, to be used as an anti-streptococcal vaccine.
    García PC; Paillavil BA; Scioscia N; Dale JB; Legarraga P; Salazar-Echegarai FJ; Bueno SM; Kalergis AM; Wozniak A
    Microbiol Immunol; 2018 Nov; 62(11):711-719. PubMed ID: 30357922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice.
    Torres-Escobar A; Juárez-Rodríguez MD; Gunn BM; Branger CG; Tinge SA; Curtiss R
    Infect Immun; 2010 Jun; 78(6):2529-43. PubMed ID: 20308296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Yersinia pestis V protein epitopes recognized by CD4 T cells.
    Parent MA; Berggren KN; Mullarky IK; Szaba FM; Kummer LW; Adamovicz JJ; Smiley ST
    Infect Immun; 2005 Apr; 73(4):2197-204. PubMed ID: 15784563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LcrV plague vaccine with altered immunomodulatory properties.
    Overheim KA; Depaolo RW; Debord KL; Morrin EM; Anderson DM; Green NM; Brubaker RR; Jabri B; Schneewind O
    Infect Immun; 2005 Aug; 73(8):5152-9. PubMed ID: 16041032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection.
    Chattopadhyay A; Park S; Delmas G; Suresh R; Senina S; Perlin DS; Rose JK
    Vaccine; 2008 Nov; 26(50):6329-37. PubMed ID: 18832004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune response elicited by DNA vaccination using Lactococcus lactis is modified by the production of surface exposed pathogenic protein.
    Pontes D; Azevedo M; Innocentin S; Blugeon S; Lefévre F; Azevedo V; Miyoshi A; Courtin P; Chapot-Chartier MP; Langella P; Chatel JM
    PLoS One; 2014; 9(1):e84509. PubMed ID: 24465412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of immune response to an antigen delivered by vaccinia virus by displaying the antigen on the surface of intracellular mature virion.
    Embry A; Meng X; Cantwell A; Dube PH; Xiang Y
    Vaccine; 2011 Jul; 29(33):5331-9. PubMed ID: 21664218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 immunostimulating complexes or Yersinia HSP60 plus interleukin-12.
    Noll A; AutenriethIB
    Infect Immun; 1996 Aug; 64(8):2955-61. PubMed ID: 8757820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice.
    Heine SJ; Franco-Mahecha OL; Chen X; Choudhari S; Blackwelder WC; van Roosmalen ML; Leenhouts K; Picking WL; Pasetti MF
    Immunol Cell Biol; 2015 Aug; 93(7):641-52. PubMed ID: 25776843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M-protein antigens derived from Group A Streptococcus.
    Wozniak A; Scioscia N; García PC; Dale JB; Paillavil BA; Legarraga P; Salazar-Echegarai FJ; Bueno SM; Kalergis AM
    Microbiol Immunol; 2018 Jun; 62(6):395-404. PubMed ID: 29704396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.
    Mannam P; Jones KF; Geller BL
    Infect Immun; 2004 Jun; 72(6):3444-50. PubMed ID: 15155651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
    Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
    Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.
    Vogel U; Autenrieth IB; Berner R; Heesemann J
    Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of an oral live vaccine for veterinary use against pseudotuberculosis.
    Quintard B; Petit T; Ruvoen N; Carniel E; Demeure CE
    Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e59-65. PubMed ID: 20034670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
    Fisher ML; Castillo C; Mecsas J
    Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
    Uppada SB; Bhat AA; Sah A; Donthamshetty RN
    Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diminished LcrV secretion attenuates Yersinia pseudotuberculosis virulence.
    Bröms JE; Francis MS; Forsberg A
    J Bacteriol; 2007 Dec; 189(23):8417-29. PubMed ID: 17873031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.